Status | Study |
Active, not recruiting |
Study Name: Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome Condition: Cutaneous Malignant Melanoma Date: 2012-12-05 Interventions: Drug: Vitamin D |
Recruiting |
Study Name: Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients Condition: Cutaneous Melanoma Date: 2012-11-14 Interventions: Biological: CSF470 vaccine, BCG, Molgramostim |
No longer available |
Study Name: Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver Condition: Metastatic Liver Cancer Ocular Melanoma Date: 2012-11-13 Interventions: Drug: Melphalan Device: Percutaneous Hepat |
Completed |
Study Name: Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma Condition: N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma Date: 2012-09-14 Interventions: Drug: Pimasertib Pimasertib wi |
Completed |
Study Name: Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma Condition: Cutaneous Malignant Melanoma Date: 2011-11-26 Interventions: Procedure: Biopsy Biopsy Other Name: n.a. |
Recruiting |
Study Name: A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma Condition: Advanced Cutaneous Melanoma Date: 2011-11-15 Interventions: Other: Non-Interventional Non-Interventional |
Terminated |
Study Name: Drosophila-generated CTL Condition: Metastatic Cutaneous Melanoma Date: 2011-01-06 Interventions: Drug: fludarabine Fludarabine |
Terminated |
Study Name: Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma Condition: Melanoma Date: 2009-10-14 |
Completed |
Study Name: Pilot Study of Infrared Imaging of Cutaneous Melanoma Condition: Melanoma Date: 2009-06-01 |
Completed |
Study Name: Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma Condition: Melanoma Date: 2008-08-22 Interventions: Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided |